Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

cyclosporine / Generic mfg.

NCT00290641: Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer

Completed

N/A

filgrastim, graft-versus-tumor induction therapy, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, radiation therapy

Masonic Cancer Center, University of Minnesota, National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes

01/06

NCT00253552: G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

Terminated

N/A

filgrastim, busulfan, cyclophosphamide, cyclosporine, etoposide, methotrexate, allogeneic bone marrow transplantation, radiation therapy

OHSU Knight Cancer Institute, National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Sarcoma

05/06

NCT00290628: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Terminated

N/A

anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, filgrastim, melphalan, methylprednisolone, mycophenolate mofetil, radiation therapy, umbilical cord blood transplantation

Masonic Cancer Center, University of Minnesota, National Cancer Institute (NCI)

Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases

04/07



	Diseases Companies Products Productz Mechanisms of Action Sites